{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/66b3d7545063c053dfbd50bb/6a04ea5d7ffb55d019dba4ad?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"E42 - Rewiring the Brain: Ketamine and the Future of Psychiatry with Meghan McCann, PMHNP","description":"<p>Ketamine may be the most misunderstood breakthrough in modern psychiatry. On this episode, Meghan McCann, board-certified psychiatric mental health nurse practitioner and owner of Velara Wellness in San Diego, joins us to explore how ketamine has been safely used in medicine since the 1970s and why its ability to target glutamate, rather than serotonin, gives it a reported 70% efficacy rate compared to the 30-40% of traditional antidepressants. Meghan breaks down how ketamine therapy literally rewires the brain, what the therapeutic experience looks and feels like, and how it is being used beyond depression for chronic pain, postpartum depression, and even end-of-life care.</p>","author_name":"Break the Psycle"}